Full-Time

Research Scientist

Primary Pharmacology

Posted on 9/9/2025

Recursion Pharmaceuticals

Recursion Pharmaceuticals

501-1,000 employees

Clinical-stage biotechnology company for drug discovery

Compensation Overview

£52k - £70.4k/yr

+ Annual Bonus + Equity Compensation

Oxford, UK

In Person

Category
Biology & Biotech (2)
,
Requirements
  • BSc/MSc/Ph.D. in Oncology, Biology, Pharmacology, or related discipline; or equivalent experience, preferably in the pharmaceutical/biotechnology industry.
  • Proficiency in sterile techniques and cell culture.
  • Expertise in in vitro assay development and optimisation
  • Hands-on experience with cell and plate-based assays (e.g., proliferation, cell binding, target engagement, cytokine release, tumour killing)
  • Practical knowledge of a wide range of assay technologies (e.g., FRET, flow cytometry, imaging)
  • Experience in small molecule high-throughput screening, including dose-response relationship analysis
  • Ability to work in a highly dynamic, fast-paced cross-functional environment
Responsibilities
  • Develop cell-based and biochemical assays to help drive development of small molecule therapeutics with a focus on compound characterisation and the rapid identification of candidate molecules.
  • Implement latest scientific developments and evaluate new technologies.
  • Collaborate with cross functional project teams to drive drug discovery programs forward by producing decision making data in timely manner
  • Engage in continual learning and development, gaining exposure to multiple scientific disciplines and the drug discovery process, from initial target identification through to candidate selection
Recursion Pharmaceuticals

Recursion Pharmaceuticals

View

Recursion is a clinical-stage biotechnology company utilizing a synchronized combination of hardware, software, and data to industrialize drug discovery and decode complex biology, reshaping the traditional drug discovery funnel through technological innovations. Their approach integrates biology, chemistry, automation, and data science to build a next-generation biopharmaceutical company.

Company Size

501-1,000

Company Stage

Post IPO Equity

Headquarters

Salt Lake City, Utah

Founded

2013

Growth & Insights

Headcount

6 month growth

1%

1 year growth

1%

2 year growth

1%
INACTIVE